Introduction {#s2}
============

Assessment of brain pathology in the consensus protocols for pathological diagnosis of dementia has been based on semiquantitative methods [@pmed.1000180-McKeith1]--[@pmed.1000180-Nation1]. These protocols aspire to distinguish demented and nondemented individuals using thresholds of plaques, neurofibrillary tangles (NFTs), infarcts, and Lewy bodies, so that pathology becomes the "gold standard" for diagnosis. This approach has progressed understanding of clinical phenotypes, genetics, biochemistry, and molecular pathogenesis associated with cognitive decline in older people. Trials of disease modifying therapies are already in progress and proponents of a vascular basis for cognitive dysfunction propose secondary prevention strategies in older people [@pmed.1000180-Cechetto1]. The scale of the clinical and social problem presented by dementia in ageing populations presents an urgent need to assess the likely impact and cost effectiveness of new, potentially expensive, therapies, and to develop robust biomarkers for diagnosis and progression. Understanding the population impact of therapies that modify the pathobiology of dementia requires an understanding of the burden of cognitive dysfunction directly attributable to a particular pathology. Recently reported trials in Alzheimer disease (AD), alleging divergent outcomes for inhibition of amyloid gamma-secretase and tau aggregation, exemplify this need [@pmed.1000180-Green1],[@pmed.1000180-Wischik1]. These are issues about which conventional case-control cohorts and studies in secondary referral populations, memory clinics, or community volunteers are less informative than the population approach used here. Selection biases are associated with non--population-based studies of older people and lead to unknown effects so that their conclusions may not generalise to the whole population.

Dementia is associated with a high prevalence of mixed Alzheimer, vascular, and other pathologies, and the thresholds of severity that clearly distinguish between an AD brain and the brain of a nondemented individual only capture around 20% of demented people [@pmed.1000180-NeuropathologyGroupofMRC1]--[@pmed.1000180-Halliday1]. True population-based studies of dementia combining longitudinal assessment of clinical state with post mortem brain donation are rare but offer the only means at present of investigating the population-level impact of pathology on cognition [@pmed.1000180-Zaccai1]. The Cognitive Function and Ageing Study (CFAS) autopsy donor cohort is now of sufficient size to facilitate true "epidemiological neuropathology." Here we present estimates of the attributable risk of dementia at death associated with specific neuropathological features in this cohort.

Methods {#s3}
=======

Ethics Statement {#s2a}
----------------

All procedures received approval from a multicentre Research Ethics Committee. MRC Cognitive Function and Ageing Study (MRC CFAS) is a population-based longitudinal study of people, in their 65th year and over, enrolled from the population-based registers of primary care physicians in six sites in England and Wales [@pmed.1000180-MRC1]. In 1990 these registers provided full geographical population coverage including people living in institutional settings.

In each of five centres random samples generated a recruited cohort of 2,500 individuals per centre (82% response rate) with equal numbers below and above 75 y. Trained interviewers conducted interviews with participants, including basic sociodemographic questions, cognitive examination, and items from the Geriatric Mental State (GMS) organicity scale, activities of daily living, physical health, and medication (see [www.cfas.ac.uk](http://www.cfas.ac.uk)).

A 20% stratified sample underwent detailed assessment (GMS [@pmed.1000180-Copeland1], augmented CAMCOG [@pmed.1000180-Huppert1]) repeated after 2 y. This assessment group included those individuals with cognitive impairment and a random sample from the same centre. There were two re-interview cycles of all survivors and several follow-ups in the assessment group only. Study flow is shown in [Figure 1](#pmed-1000180-g001){ref-type="fig"}. Diagnoses were made using the validated AGECAT algorithm [@pmed.1000180-Copeland2].

![MRC CFAS design.\
Numbers of interviews and donations from interview waves.](pmed.1000180.g001){#pmed-1000180-g001}

In the sixth centre (Liverpool) 5,200 people aged 65 y and over, in equal numbers across 5-y bands, were recruited with a population sampling base. This study (ALPHA) started before the other sites but its design and methods enable it to be integrated into CFAS. Interviews in ALPHA were based on GMS and study flow is shown in [Figure 2](#pmed-1000180-g002){ref-type="fig"}.

![MRC Alpha Study (Liverpool) design.\
Numbers of interviews and donations from each interview wave.](pmed.1000180.g002){#pmed-1000180-g002}

Individuals, families, and carers in the assessment group were approached by trained liaison officers and invited to participate in counselling around brain donation. Those who agreed to brain donation were provided with information to allow staff or family involved in the final illness to notify the death and initiate brain donation. Donations still proceeded, wherever possible, for cases coming to autopsy under the coroner.

There were 456 individuals in this analysis, representing all completed brain donations before 1st August 2004. The sample includes 207 individuals previously described (two families contributing to that previous cohort subsequently revoked consent and the data were removed) [@pmed.1000180-NeuropathologyGroupofMRC1].

Dementia status was established using multiple information sources including AGECAT, notification of dementia in death certificates, a retrospective informant interview (RINI; [www.cfas.ac.uk](http://www.cfas.ac.uk)) with relatives and carers after death, and the probability of being demented before death from a Bayesian analysis of all individuals modelling the prevalence and incidence of dementia in CFAS. We could not assign dementia status in 30 individuals in whom the study diagnosis was "not dementia." These respondents were not included in the analysis because their last interview was more than 6 mo before death, no RINI was available, and dementia was not mentioned on the death certificate.

The neuropathology protocol used standardised assessment of paraffin-embedded tissues to record data using the Consortium to Establish a Registry of Alzheimer\'s Disease (CERAD) protocol [@pmed.1000180-Mirra1]. CERAD data were augmented by a strategy for evaluating white matter lesions (WML) in the post mortem brain previously validated against histopathology [@pmed.1000180-Fernando1]. Neuropathology was assessed without knowledge of clinical, interview, or RINI data. Acceptable inter-rater reliability (\<5% with scores more than 1 grade difference) was achieved for cerebral cortical atrophy, NFT, amyloid plaques (diffuse and neuritic), Lewy bodies, and cerebral amyloid angiopathy by circulation of macroscopic brain photographs and microscopic slides.

Statistical Methods {#s2b}
-------------------

Sample characteristics were compared with the overall population using Chi-squared for association and Mann-Whitney for the median age of death. Unconditional logistic regression analysis examined the effect of neuropathological variables and age on dementia at death. Backwards stepwise logistic regression (*p = *0.1) assisted model selection. Interactions between pathologies were tested using likelihood ratio tests. The chosen final model best predicted dementia status at death for the least number of factors within the model. The method maximised the sensitivity and specificity using the predicted probabilities from the model, and minimised the number of individuals for whom prediction was not possible.

Using the model most likely to correctly predict dementia we estimated the partial "population attributable risk" (AR) at death, conditional on all other factors, from the adjusted logistic regression [@pmed.1000180-Land1]. These AR estimates represent the amount of dementia at death in the sample determined by each factor in the model, relative to the reference category, using both the risk and the prevalence of that factor. The AR represents the proportion of dementia at death accounted for after elimination of that risk factor if the remaining distribution of the risk factors remains unchanged. Bootstrap confidence intervals were calculated [@pmed.1000180-Efron1]. The amount of missing data was small (\<5%) except for brain weight (10%), macroscopic vascular disease (7%) and diffuse plaques in the entorhinal campus/hippocampus (6%). A sensitivity analysis of the model and PAR estimates was undertaken using multiple imputations using chain equations to impute the data for all individuals with unknown factors in the model process [@pmed.1000180-Rubin1]. Ten imputation datasets were used. Analysis was undertaken using Stata software, version 9.2 (Stata Corp.) and the R software package ([www.r-project.org](http://www.r-project.org)).

Results {#s4}
=======

Representativeness of the Brain Donor Cohort {#s3a}
--------------------------------------------

There were no significant differences between the donor cohort and all respondents who died with respect to sex and length in fulltime education ([Table 1](#pmed-1000180-t001){ref-type="table"}). Individuals who donated brain tissue were significantly older than all deaths in the population sample, and also than all individuals still alive on 1st August 2004. More donors were in the "manual" social class compared with all who died (*p = *0.03). There was no significant difference between the brain donor cohort and the CFAS baseline sample with respect to sex, social class, and length in fulltime of education.

10.1371/journal.pmed.1000180.t001

###### Demographic characteristics of baseline population, deaths, and donors (six centres).

![](pmed.1000180.t001){#pmed-1000180-t001-1}

  Characteristics                  Baseline *n = *18,248   Percent    IQR     Died but Not Donors *n = *11,465   Percent    IQR    Donors *n = *456   Percent    IQR     Donors Versus All Died but Not Donors
  ------------------------------- ----------------------- --------- -------- ---------------------------------- --------- ------- ------------------ --------- -------- ---------------------------------------
  **Centre**                                                                                                                                                            
  Cambridge                                2,601             14       ---                  1,465                   13       ---           96            21       ---                      ---
  Gwynedd                                  2,625             14       ---                  1,387                   12       ---           9              2       ---                      ---
  Liverpool                                5,244             29       ---                  4,065                   35       ---          101            22       ---                      ---
  Newcastle                                2,524             14       ---                  1,549                   14       ---           55            12       ---                      ---
  Nottingham                               2,514             14       ---                  1,423                   13       ---          127            28       ---                      ---
  Oxford                                   2,740             15       ---                  1,526                   13       ---           68            15       ---                      ---
  **Sex**                                                                                                                                                               
  Men                                      7,625             42       ---                  5,164                   45       ---          188            41       ---                      ---
  Women                                   10,623             58       ---                  6,301                   55       ---          268            59       ---                  *p = *0.11
  **Age group at baseline (y)**                                                                                                                                         
  \<74                                     8,231             45       ---                  3,557                   31       ---          100            22       ---                      ---
  75--84                                   6,982             38       ---                  5,159                   45       ---          215            47       ---                      ---
  85--94                                   2,849             16       ---                  2,573                   22       ---          135            29       ---                      ---
  \>94                                      186               1       ---                   176                     2       ---           6              2       ---                  *P\<*0.001
  **Median age (y)**                        70               ---     67--74                  79                    ---     73,84          81            ---     76--86                    ---
  **Education**                                                                                                                                                         
  Missing                                   566               3       ---                   483                     4       ---           32             6       ---                      ---
  0--9 y                                  11,985             66       ---                  7,812                   68       ---          302            67       ---                      ---
  \>9 y                                    5,697             32       ---                  3,170                   28       ---          122            27       ---                  *p = *0.97
  **Social class**                                                                                                                                                      
  Missing                                  1,371              8       ---                  1,035                    9       ---           57            13       ---                      ---
  Nonmanual                                6,574             36       ---                  3,717                   32       ---          165            36       ---                      ---
  Manual                                  10,303             56       ---                  6,713                   59       ---          234            51       ---                  *p = *0.02
  **Age group at death (y)**                                                                                                                                            
  \<74                                      ---              ---      ---                  1,187                   10       ---           43            27       ---                      ---
  75--84                                    ---              ---      ---                  4,601                   40       ---          125            50       ---                      ---
  85--94                                    ---              ---      ---                  4,782                   42       ---          229            13       ---                      ---
  \>94                                      ---              ---      ---                   895                     8       ---           59            ---     82--92                *P\<*0.001
  **Median age at death**                   ---              ---      ---                    84                    ---     79,90          87            ---      ---                      ---

IQR, interquartile range.

Prevalence of Neuropathologies in Old People {#s3b}
--------------------------------------------

Neurodegenerative pathology in the cohort is shown in [Tables 2](#pmed-1000180-t002){ref-type="table"} and [3](#pmed-1000180-t003){ref-type="table"}. NFT were the most prevalent degenerative pathology in the hippocampus and entorhinal cortex (92%). In the neocortex NFT were less (52%), and neuritic plaques more (68%), prevalent. Neuronal loss in hippocampus and subcortical nuclei was reported in 40% and 60% of the sample, respectively. Lewy bodies were found in less than 10% of brains (mainly substantia nigra) reflecting the use of older techniques (hematoxylin--eosin or ubiquitin staining) rather than synuclein staining. These factors are shown in relation to dementia status in [Tables 4](#pmed-1000180-t004){ref-type="table"} and [5](#pmed-1000180-t005){ref-type="table"}. Neocortical, hippocampal, and entorhinal cortex pathology was more common in individuals with dementia. Vascular pathology was frequently observed (not demented 71%, demented 84%), most frequently as small vessel disease (SVD; not demented 60%, demented 77%; odds ratio \[OR\] for dementia 1.6, 95% confidence interval \[CI\] 0.9--2.8). This diagnosis of SVD is based exclusively on histological criteria. Periventricular white matter lesions (PVL) were common (not demented 87%, demented 95%, OR for dementia with severe PVL 4.3, 95% CI 1.9--9.8), though deep white matter lesions (DWMLs) were less common (not demented 60%, demented 73%, OR for dementia with severe DWML 3.3, 95% 1.6--6.8). A combined diagnosis including both WML and histological SVD was overrepresented among the demented group (32% versus 24%; OR for dementia 2.9, 95% CI 1.6--5.5). Cerebral amyloid angiopathy (CAA) was overrepresented in the demented group (34% versus 10%; OR for dementia 4.3, 95% CI 2.4--7.6). Neocortical and hippocampal atrophy were both common in individuals with dementia (75% and 67%), though less so in the nondemented (43% and 31%), and therefore have a very large association with dementia (severe atrophy OR\>10).

10.1371/journal.pmed.1000180.t002

###### Number of individuals with neuropathology findings in medial temporal and neocortical regions.

![](pmed.1000180.t002){#pmed-1000180-t002-2}

  Neuropathology            Severity     Hippocampus   Percent   Entorhinal   Percent   Frontal   Temporal   Parietal   Occipital   Overall   Percent
  ---------------------- -------------- ------------- --------- ------------ --------- --------- ---------- ---------- ----------- --------- ---------
  **Neuritic plaques**      **None**         191         42         178         39        185       171        194         200        143       31
                            **Mild**         97          21         122         27        140       111        114         74         104       23
                          **Moderate**       123         27         106         23        91        123        108         80         139       31
                           **Severe**        39           9          41          9        37         50         38         23         70        15
                          **Missing**         6           1          9           2         3         1          2          79          0         0
  **Diffuse plaques**       **None**         203         45         142         31        134       130        151         143        115       25
                            **Mild**         128         28         110         24        106        95        107         94         95        21
                          **Moderate**       84          18         124         27        94        122         92         100        112       25
                           **Severe**        16           4          51         11        103        92         88         37         120       26
                          **Missing**        25           5          29          6        19         17         18         82         14         3
  **Tangles**               **None**         51          11          39          9        298       230        295         299        216       47
                            **Mild**         118         26          94         21        101       124         94         38         129       28
                          **Moderate**       134         30         185         41        40         62         47         26         70        15
                           **Severe**        147         32         128         28        11         37         11          9         39         9
                          **Missing**         6           1          10          2         6         7          9          84          2         1
  **Neuronal loss**         **None**         287         63         287         63        432       430        430         384        425       93
                            **Mild**         67          15          53         12        10         12         7           3         19         4
                          **Moderate**       39           9          46         10         0         0          0           0          0         0
                           **Severe**        37           8          34          7         0         0          0           0          0         0
                          **Missing**        26           6          36          8        14         14         19         69         12         3
  **Lewy bodies**           **None**         432         95         409         90        433       424        428         380        425       93
                            **Mild**          6           1          13          3         8         16         4           2         18         4
                          **Moderate**        0           0          4           1         0         0          0           0          0         0
                           **Severe**         0           0          1           0         0         0          0           0          0         0
                            Missing          18           4          29          6        15         16         24         74         13         3

10.1371/journal.pmed.1000180.t003

###### Number of individuals with neuropathology findings in subcortical nuclei.

![](pmed.1000180.t003){#pmed-1000180-t003-3}

  Neuropathology               Severity           Substantia Nigra   Nucleus Basalis   Raphé   Locus Ceruleus   Dorsal Vagus   Overall   Percent
  ------------------- -------------------------- ------------------ ----------------- ------- ---------------- -------------- --------- ---------
  **Plaques**                  **None**                 389                202          271         283             194          353       77
                               **Mild**                  2                 30            8           1               0           36         8
                             **Moderate**                0                 13            0           0               0           13         3
                              **Severe**                 0                  0            0           0               0            0         0
                       **Missing/not measured**          65                211          177         172             262          54        12
  **Tangles**                  **None**                 314                93           157         166             207          177       39
                               **Mild**                  89                104          78          105              11          122       26
                             **Moderate**                13                49           52           42              0           77        17
                              **Severe**                 20                47           36           14              0           71        15
                             **Missing**                 20                163          133         129             238           9         2
  **Neuronal loss**            **None**                 217                205          298         216             230          183       40
                               **Mild**                 175                61           23           84              27          175       38
                             **Moderate**                36                23            2           27              14          67        15
                              **Severe**                 16                 6                        11              3           25         6
                             **Missing**                 12                161          133         118             182           6         2
  **Lewy bodies**              **None**                 409                286          327         313             258          406       89
                               **Mild**                  19                10            2           15              7           20         4
                             **Moderate**                11                 1            0           9               10          18         4
                              **Severe**                 8                  0            0           1               0            9         2
                             **Missing**                 9                 159          127         118             181           3         1

10.1371/journal.pmed.1000180.t004

###### Number of individuals by neuropathology and dementia status at death.

![](pmed.1000180.t004){#pmed-1000180-t004-4}

  Neuropathological Findings                        Severity         No Dementia *n = *183   Percent   Dementia *n = *243   Percent   Uncertain *n = *30   Percent
  ------------------------------------------- --------------------- ----------------------- --------- -------------------- --------- -------------------- ---------
  **Neocortex: neuritic plaques**                   **None**                  83               45              47             19              13             43
                                                    **Mild**                  51               28              44             18              9              30
                                                  **Moderate**                43               24              89             37              7              23
                                                   **Severe**                  6                3              63             26              1               3
  **Neocortex: diffuse plaques**                    **None**                  54               30              38             16              9              30
                                                    **Mild**                  43               24              42             18              4              13
                                                  **Moderate**                56               31              60             26              9              30
                                                   **Severe**                 28               15              91             39              8              27
                                                   **Missing**                12               ---             12             ---             0              ---
  **Neocortex: NFT**                                **None**                  114              63              81             33              21             67
                                                    **Mild**                  59               33              63             26              7              22
                                                  **Moderate**                 8                4              60             25              2              11
                                                   **Severe**                  0                0              39             16              0               0
  **Neocortex: atrophy**                            **None**                  101              57              57             25              15             50
                                                    **Mild**                  51               29              52             23              12             40
                                                  **Moderate**                24               14              94             41              2               7
                                                   **Severe**                  1                1              28             12              0               0
                                                   **Missing**                 6               ---             12             ---             1              ---
  **Hippocampus:** **neuritic plaques**             **None**                  106              58              67             28              18             60
                                                    **Mild**                  37               20              57             24              3              10
                                                  **Moderate**                33               18              83             35              7              23
                                                   **Severe**                  6                3              31             13              2               7
                                                   **Missing**                 1               ---             5              ---             0              ---
  **Hippocampus:** **diffuse plaques**              **None**                  101              56              89             40              13             43
                                                    **Mild**                  47               26              70             32              11             37
                                                  **Moderate**                26               15              53             24              5              17
                                                   **Severe**                  5                3              10              5              1               3
                                                   **Missing**                 4               ---             21              9              0              ---
  **Hippocampus:** **NFT**                          **None**                  34               19              12              5              5              17
                                                    **Mild**                  68               37              39             16              11             37
                                                  **Moderate**                53               29              72             30              9              30
                                                   **Severe**                 27               15             115             48              5               3
                                                   **Missing**                 1               ---             5              ---             0               0
  **Hippocampus: atrophy**                          **None**                  117              69              71             33              16             57
                                                    **Mild**                  33               19              47             22              9              32
                                                  **Moderate**                17               11              78             36              2               7
                                                   **Severe**                  2                1              18              8              1               4
                                                   **Missing**                14               ---             29             ---             2               2
  Entorhinal cortex: neuritic plaques               **None**                  100              55              61             26              17             57
                                                    **Mild**                  49               27              64             27              9              30
                                                  **Moderate**                28               15              75             32              3              10
                                                   **Severe**                  5                3              35             15              1               3
                                                   **Missing**                 1               ---             8              ---             0              ---
  **Entorhinal cortex: diffuse plaques**            **None**                  81               46              51             23              10             33
                                                    **Mild**                  42               24              58             26              10             33
                                                  **Moderate**                44               25              73             33              7              23
                                                   **Severe**                 11                6              37             17              3              10
                                                   **Missing**                 5               ---             24             ---             0              ---
  **Entorhinal cortex: NFT**                        **None**                  27               15              7               3              5              17
                                                    **Mild**                  55               30              30             13              9              30
                                                  **Moderate**                77               43              98             42              10             33
                                                   **Severe**                 22               12             100             43              6              20
                                                   **Missing**                 2               ---             8              ---             0              ---
  **Lewy bodies**                                    **---**                  10                5              35             14              3              10
  **Brain weight** kg -- median                      **---**                 1.24              ---            1.11            ---            1.15            ---
  **Age at death (y)**                              **\<80**                  57               32              25             10              7              23
                                                   **80--89**                 79               43             110             45              15             50
                                                     **≥90**                  47               26             108             44              8              27
  **CAA**                                           **None**                  131              73             102             43              23             77
                                                    **Mild**                  31               17              54             23              4              13
                                                  **Moderate**                17               10              64             27              2               7
                                                   **Severe**                  0                0              17              7              1               3
                                                   **Missing**                 5               ---             5              ---             0              ---
  **Moderate/severe CAA**                            **---**                  17               10              81             34              3              13
  Vascular disease                                                                                                                                        
  **Any vascular disease**                           **---**                  122              71             196             84              24             83
  **Haemorrhage**                                    **---**                   9                5              9               4              1               4
  **Infarct**                                        **---**                  43               24              80             34              14             48
  **Lacune**                                         **---**                  30               17              62             26              7              24
  **SVD**                                            **---**                  104              60             178             77              18             64
  Overall vascular pathology                         **---**                  18               ---            ---             ---            ---             ---
  **None**                                           **---**                  50               29              38             17              5              18
  **One of infarct/lacune/haemorrhage**              **---**                  14                8              9               4              3              11
  **SVD only**                                       **---**                  56               33              76             34              8              29
  **Multiple**                                       **---**                  50               29             102             45              12             43
  **Missing**                                        **---**                  18               ---             13             ---             2              ---
  **Periventricular WML**                           **None**                  21               13              11              5              2               7
                                                    **Mild**                  95               58             100             44              19             66
                                               **Moderate/severe**            49               29             114             51              8              28
                                                   **Missing**                19               ---             17             ---             1              ---
  **Deep subcortical WML**                          **None**                  71               40              62             27              12             41
                                                    **Mild**                  67               38              97             41              12             41
                                                  **Moderate**                24               14              36             15              4              14
                                                   **Severe**                 14                8              39             17              1               3
                                                   **Missing**                 9               ---             4              ---             1              ---
  **Histological/imaging vascular disease**                                                                                                               
  **None**                                           **---**                  44               25              26             11              5              17
  **Infarct or haemorrhage**                         **---**                   7                4              5               2              1               3
  **Lacunes/SVD/DWML**                               **---**                  84               47             130             55              11             37
  **Both**                                           **---**                  43               24              77             32              13             43
  **Missing**                                        **---**                   5               ---             5              ---             0              ---

10.1371/journal.pmed.1000180.t005

###### Unconditional logistic regression adjusted for age and multivariable analyses and estimated partial AR at death for dementia.

![](pmed.1000180.t005){#pmed-1000180-t005-5}

  Neuropathological Findings                       Age Adjusted Analysis   Multivariable Analysis     AR                                              
  ----------------------------------------------- ----------------------- ------------------------ --------- -------------- ---------- -------------- ---------
  **Age at death (y)**                                                                                                                                
  **\<80**                                                  1.0                   **---**             ---         1.0          ---          ---        **---**
  **80--89**                                                3.2                   1.8--5.5            ---         2.5        1.1--5.8        8          0--16
  **≥90**                                                   5.2                   2.9--9.4          \<0.001       3.4        1.4--8.3        10         3--16
  **Time since last interview (y)**                       **---**                 **---**             ---     Not included     ---      Not included   **---**
  **\<1**                                                   1.0                   **---**             ---         ---          ---          ---        **---**
  **\>1**                                                   1.2                   0.8--1.7            0.5         ---          ---          ---        **---**
  **Brain weight for sex (g)**                                                                                                                        
  **Low**                                                   5.7                   3.2--10           \<0.001       4.1        1.9--9.2        12         5--19
  **Average**                                               2.0                   1.2--34             ---         2.1        1.0--4.2        5          0--11
  **High**                                                  1.0                   **---**             ---         1.0          ---          ---        **---**
  **Neuritic plaques in neocortex**                                                                                                                   
  **None**                                                  1.0                   **---**             ---         1.0          ---          ---        **---**
  **Mild**                                                  1.2                   0.7--2.2            ---         1.0          ---          ---        **---**
  **Moderate**                                              2.9                   1.7--5.0            ---         1.0          ---          ---        **---**
  **Severe**                                               18.5                   7.3--47           \<0.001       9.7        2.1--43         8          3--14
  **Diffuse plaques in neocortex**                        **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---                     **---**
  **Mild**                                                  1.4                   0.7--2.5            ---         ---          ---          ---        **---**
  **Moderate**                                              1.6                   0.9--2.9            ---         ---          ---          ---        **---**
  **Severe**                                                4.2                   2.3--7.9          \<0.001       ---          ---          ---        **---**
  **NFT in neocortex**                                                                                                                                
  **None**                                                  1.0                   **---**             ---         1.0          ---          ---        **---**
  **Mild**                                                  1.3                   0.8--2.1            ---         1.0        0.5--1.8       ---        **---**
  **Moderate**                                              8.9                   4.0--20             ---         7.1        2.3--22         11         5--19
  **Severe**                                                 ∞                    **---**           \<0.001       ---          ---          ---        **---**
  **Neuritic plaques in hippocampus**                     **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.9                   1.1--3.3            ---         ---          ---          ---        **---**
  **Moderate**                                              3.5                   2.1--5.9            ---         ---          ---          ---        **---**
  **Severe**                                                8.5                   3.2--22           \<0.001       ---          ---          ---        **---**
  **Diffuse plaques in hippocampus**                      **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.5                   0.9--2.5            ---         ---          ---          ---        **---**
  **Moderate**                                              2.0                   1.1--3.5            ---         ---          ---          ---        **---**
  **Severe**                                                2.2                   0.7--7.2           0.06         ---          ---          ---        **---**
  **Tangles in hippocampus**                              **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.3                   0.6--2.8            ---         ---          ---          ---        **---**
  **Moderate**                                              2.7                   1.2--5.9            ---         ---          ---          ---        **---**
  **Severe**                                                8.4                   3.7--19           \<0.001       ---          ---          ---        **---**
  **Neuritic plaques in the entorhinal cortex**           **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.9                   1.1--3.1            ---         ---          ---          ---        **---**
  **Moderate**                                              3.7                   2.1--6.5            ---         ---          ---          ---        **---**
  **Severe**                                               11.1                   4.0--30           \<0.001       ---          ---          ---        **---**
  **Diffuse plaques in the entorhinal cortex**            **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  2.2                   1.3--3.8            ---         ---          ---          ---        **---**
  **Moderate**                                              2.6                   1.5--4.4            ---         ---          ---          ---        **---**
  **Severe**                                                5.5                   2.5--12           \<0.001       ---          ---          ---        **---**
  **Tangles in entorhinal cortex**                        **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.7                   0.6--4.5            ---         ---          ---          ---        **---**
  **Moderate**                                              3.4                   1.4--8.6            ---         ---          ---          ---        **---**
  **Severe**                                               12.7                   4.8--34           \<0.001       ---          ---          ---        **---**
  **CAA**                                                                                                                                             
  **None**                                                  1.0                   **---**             ---         1.0          1.0          ---        **---**
  **Mild**                                                  1.9                   1.1--3.3            ---         1.8        0.8--3.8        2          0--6
  **Moderate**                                              4.0                   2.2--7.4            ---         2.9        1.2--6.8        5          1--10
  **Severe**                                                 ∞                    **---**           \<0.001       2.9        1.2--6.8        5          1--10
  **Moderate/severe CAA**                                 **---**                 **---**             ---     Not included     ---      Not included   **---**
  **No**                                                    1.0                   **---**             ---         ---          ---          ---        **---**
  **Yes**                                                   4.3                   2.4--7.6          \<0.001       ---          ---          ---        **---**
  **Lewy bodies**                                                                                                                                     
  **No**                                                    1.0                     1.0               ---         1.0          ---          ---        **---**
  **Yes**                                                   3.2                   1.5--6.9          \<0.003       3.5        1.3--9.3        3          1--7
  **Vascular disease (VD)**                               **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **One of infarct/lacune/haemorrhage**                     0.7                   0.3--1.9            ---         ---          ---          ---        **---**
  **SVD only**                                              1.6                   0.9--2.8            ---         ---          ---          ---        **---**
  **Multiple**                                              2.5                   1.4--4.3          \<0.004       ---          ---          ---        **---**
  **Overall vascular pathology**                                                                                                                      
  **None**                                                  1.0                   **---**             ---         1.0          ---          ---        **---**
  **Infarcts/haemorrhage**                                  1.0                   0.3--3.8            ---         2.4        0.4--12        ---        **---**
  **SVD/WML/lacunes**                                       2.5                   1.4--4.4            ---         3.7        1.5--9.6        12         3--19
  **Both**                                                  2.9                   1.6--5.5          \<0.003       4.8        1.9--12         9          3--15
  **Periventricular WML**                                 **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  2.0                   0.9--4.5            ---         ---          ---          ---        **---**
  **Moderate/severe**                                       4.3                   1.9--9.8          \<0.001       ---          ---          ---        **---**
  **Deep subcortical WML**                                **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                   **---**             ---         ---          ---          ---        **---**
  **Mild**                                                  1.6                   1.0--2.6            ---         ---          ---          ---        **---**
  **Moderate**                                              1.6                   0.9--3.1            ---         ---          ---          ---        **---**
  **Severe**                                                3.3                   1.6--6.8          \<0.01        ---          ---          ---        **---**
  **Hippocampal atrophy**                                                                                                                             
  **None**                                                  1.0                     1.0               ---         1.0          1.0          ---        **---**
  **Mild**                                                  2.2                   1.3--3.9            ---         1.8        0.9--3.7        2          0--6
  **Moderate**                                              6.9                   3.7--13             ---         3.4        1.5--7.5        8          2--15
  **Severe**                                               11.1                   2.5--50           \<0.001       3.4        1.5--7.5        8          2--15
  **Neocortical atrophy**                                 **---**                 **---**             ---     Not included     ---      Not included   **---**
  **None**                                                  1.0                     1.0               ---         ---          ---          ---        **---**
  **Mild**                                                  1.6                   1.0--2.8            ---         ---          ---          ---        **---**
  **Moderate**                                              5.9                   3.3--10             ---         ---          ---          ---        **---**
  **Severe**                                               37.8                   5.0--29           \<0.01        ---          ---          ---        **---**

The multivariable logistic regression ([Table 5](#pmed-1000180-t005){ref-type="table"}) showed independent association with dementia status for: moderate and severe NFT in the neocortex; severe neuritic plaques in the neocortex; cerebral angiopathy; combined vascular disease; SVD; PVL; Lewy bodies; hippocampal atrophy; brain weight and age. All respondents with severe NFT in the neocortex (39 individuals, 16% of the demented group) were demented giving an infinite odds ratio for dementia risk and representing a perfect predictor (sufficient but not necessary). Seventy individuals had some missing neuropathology measures and were initially excluded from the modelling. Individuals whose missing data did not affect their predicted dementia status were included in the summary (48 of 70). The final prediction was therefore from a model using 404 brains (89%), which represent 4% of all the deceased respondents in CFAS.

The multivariable model ([Table 5](#pmed-1000180-t005){ref-type="table"}) correctly predicted dementia status in 80% (404 individuals) of the 426 with known dementia status (sensitivity, 71%, 95% CI 64--76; specificity, 92%, 95% CI 87--96; receiver operating characteristic \[ROC\] 0.86). Substantial neuropathology without a dementia diagnosis was found in 13 individuals (M∶F 6∶7; age at death, 81--102 y). This group includes two individuals with life-long low cognition confirmed by RINI interview. The remaining 11 had an Mini-Mental Status Examination (MMSE) \>18 (three with MMSE \>26) when they were last measured, including five (45%) who had a RINI. Median time from interview to death in those without a RINI interview was 12 mo. Only two had symptomatic cognitive impairment, but not consistently, and one had depression. The pathologies exhibited by these individuals were SVD (*n = *11), low brain weight (*n = *8), atrophy (*n = *7), severe plaques (*n = *5), and moderate NFT (*n = *4).

Conversely 68 individuals (M∶F 24∶44; age at death, 71--103 y) had a dementia diagnosis before death but showed only modest neuropathology. Sixty (88%) showed moderate or severe cognitive impairment before death. Of the other eight all had died at least 15 mo after the last interview and dementia was confirmed by RINI (*n = *6) or death certificate (*n = *3). The neuropathology was generally mild and included Lewy bodies (*n = *4). Two individuals had severe atrophy of the hippocampus. Neuropathology in the brainstem, not included in the model, was present in 36 individuals (NFT, *n = *24; plaques, *n = *4; neuronal loss, *n = *15). These factors did not improve the overall model when tested across all individuals. Other neuropathological findings in these individuals include Progressive Supranuclear Palsy, hippocampal hypoxic injury, head injury, and mesial temporal sclerosis. The outcome of interest in this analysis was dementia and it therefore does not address cognitive impairment short of dementia in which the factors reported here would also be expected to play a role.

AR of Dementia for Pathological Features {#s3c}
----------------------------------------

The risk of dementia associated with specific thresholds of pathology is shown in [Table 5](#pmed-1000180-t005){ref-type="table"}. Each estimated AR at death adjusts for all others such that 96% of the overall risk is explained. Nearly 20% of this risk is due to the effect of age. Factors conveying more than 8% each of the dementia risk were: NFT in the neocortex; age; neuritic plaques; SVD; moderate/severe atrophy; low brain weight. Alzheimer pathologies together (plaques, tangles, and CAA) account for ∼25% of dementia risk, and vascular pathologies ∼21%. Other neuropathological factors each convey between 2%--5% of the risk.

Neuropathology in the Nondemented {#s3d}
---------------------------------

Many nondemented individuals manifest "high risk" pathologies. A moderate NFT score in the neocortex is rare (4%), and a severe NFT score absent, but multiple vascular disease (24%) and SVD (47%) are common. Neuropathological factors, age, and brain weight only account for 34% of the variability within the model, despite high estimates of AR. This apparent anomaly underscores their relatively poor predictive value in making a diagnosis of dementia.

Prediction from Neuropathology Alone {#s3e}
------------------------------------

Univariate modelling of the relationship between dementia and neuropathological findings, excluding age and brain weight, showed a large additional risk associated with having NFT in the hippocampus. However this adjusted out in multivariable analysis. The model based on neuropathology data alone has higher sensitivity (83%), but lower specificity (76%). From the 399 in this model, 80% were correctly classified as either demented or not. The AR at death for neuropathological features was modified only slightly by excluding age and brain weight. The major contributor to dementia risk remained NFT (28%; neocortical, 14%; hippocampal, 14%). Atrophy (20%) and CAA (11%) were more important. Vascular factors (17%), neocortical plaques (7%), and Lewy bodies (4%) remained the same. No interactions were detected.

Sensitivity Analysis {#s3f}
--------------------

Imputation of variables with missing data was used to test the robustness of the model against both missing outcome variables (30 individuals whose dementia status was not coded) and pathology variables. The multivariable modelling after imputation showed few differences from the original model in [Table 5](#pmed-1000180-t005){ref-type="table"}. The neuropathology factors chosen to be represented in the model were checked using ten imputation datasets. Factors associated with dementia were remarkably stable within each imputation dataset. The only factors that appeared to differ were whether Lewy bodies (excluded from five datasets), severe plaques (excluded from four datasets), age (excluded from two datasets), and hippocampal atrophy (excluded from one dataset) should be included in the model. Two factors that were not previously in the models became important: NFT in the hippocampus and neuronal loss in the brainstem. Neuronal loss in the brainstem appeared important in individuals previously misclassified, but did not improve the model using the original data where there was missing data in the covariates and outcome variable. The full model with all these factors is shown in [Table 6](#pmed-1000180-t006){ref-type="table"}. The estimations of AR at death were very similar for the imputation datasets. The inclusion of brain stem neuronal loss (AR 13%) and NFT in the hippocampus (AR 5%) emerged from small reductions (1%) in the majority of factors though hippocampal atrophy (8% to 4%) and old age (11% to 8%) were more affected. Analysis adjusting for demographic differences between the brain donor cohort and the rest of the population that died showed only slight change in AR at death for factors most associated with older age (old age, atrophy, and neocortical NFT), whilst vascular disease, low brain weight, plaques, and CAA all showed small increases (1%--2%). Only low brain weight (from 11% to 18%) and atrophy (from 8% to 2%) were affected by the age difference between the donor cohort and all those who died in the population. A further sensitivity analysis only in those assessed less than 1 y prior to death was undertaken and all associations increased in strength, suggesting any bias is conservative, and all AR estimates were consistent with the confidence intervals presented.

10.1371/journal.pmed.1000180.t006

###### Sensitivity analysis: Imputation models.

![](pmed.1000180.t006){#pmed-1000180-t006-6}

  Neuropathological Findings           Multivariable Model Original   Imputed    Imputation Model                                            
  ----------------------------------- ------------------------------ ---------- ------------------ ---------- --------- ---------- --------- ---------
  **Age at death**                                                                                                                           
  **\<80 y**                                       1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **80--89 y**                                     2.5                1.1--5.8         2.3          1.1--4.8     2.1     1.0--4.5      7       1--14
  **≥90 y**                                        3.4                1.4--8.3         4.3          2.0--9.5     4.2     1.8--9.6      8       2--16
  **Brain weight for sex**                                                                                                                   
  **Low**                                          4.1                1.9--9.2         4.3          2.0--9.2     4.3     1.9--9.6     12       5--19
  **Average**                                      2.1                1.0--4.2         1.8          0.9--3.4     1.7     0.9--3.4      4       0--9
  **High**                                         1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Neuritic plaques in neocortex**                                                                                                          
  **None or mild**                                 1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Moderate or severe**                           9.7                2.1--43          4.4          1.6--12      3.9     1.3--11       7       3--17
  Tangles in neocortex                                                                                                                       
  **None**                                         1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Mild**                                         1.0                0.5--1.8         1.0          0.6--1.8     0.7     0.4--1.4   **---**   **---**
  **Moderate or severe**                           7.1                2.3--22          6.3          2.6--15      4.6     1.8--12      10       5--17
  **Tangles in hippocampus**                                                                                                                 
  **None or mild**                               **---**              **---**        **---**        **---**      1.0     **---**    **---**   **---**
  **Moderate or severe**                       Not included           **---**      Not included     **---**      1.8     1.0--3.3      5       0--12
  **CAA**                                                                                                                                    
  **None**                                         1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Mild**                                         1.8                0.8--3.8         1.7          0.9--3.3     1.5     0.7--3.0   **---**   **---**
  **Moderate or severe**                           2.9                1.2--6.8         3.5          1.7--7.4     3.8     1.7--8.2      4       0--9
  **Lewy bodies**                                                                                                                            
  **No**                                           1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Yes**                                          3.5                1.3--9.3         3.7          1.6--8.9     2.2     0.9--5.7      2       0--5
  **Overall vascular pathology**                                                                                                             
  **None**                                         1.0                **---**          1.0          **---**      1.0     **---**    **---**   **---**
  **Infarcts/haemorrhage**                         2.4                0.4--12          1.9          0.3--11      1.4     0.2--9.4   **---**   **---**
  **SVD/DWML/lacunes**                             3.7                1.5,9.6          3.1          1.4--6.9     3.3     1.4--7.5   **---**   **---**
  **Both**                                         4.8                1.9--12          4.0          1.8--9.2     4.2     1.8--9.9     20       8--33
  **Hippocampal atrophy**                                                                                                                    
  **None**                                         1.0                **---**          1.0            1.0        1.0     **---**    **---**   **---**
  **Mild**                                         1.8                0.9,3.7          1.5          0.8--2.9     1.3     0.6--2.6   **---**   **---**
  **Moderate**                                     3.4                1.5--7.5         2.8          1.4--5.6     1.9     0.9--4.2      4       0--10
  **Severe**                                     **---**              **---**        **---**        **---**    **---**   **---**    **---**   **---**
  **Brainstem neuronal loss**                                                                                                                
  **None**                                       **---**              **---**        **---**        **---**      1.0       1.0      **---**   **---**
  **Mild**                                       **---**              **---**        **---**        **---**      2.7     1.5--4.9      6       1--12
  **Moderate**                                   **---**              **---**        **---**        **---**      3.3     1.4--8.0      7       0--13
  **Severe**                                   Not included           **---**      Not included     **---**      9.9     1.8--54       7       0--13

Discussion {#s5}
==========

MRC CFAS shows that it is possible to set up and sustain a brain donation programme from a geographically dispersed, population-based study, which is not biased in terms of gender, social class, education, institutionalisation, or access to health care. The resulting brain donor sample is of sufficient size to generate meaningful estimates of AR at death associated with specific pathologies and contributes significantly to understanding the pathobiology of dementia on the basis of "epidemiological neuropathology." It also allows the separation of factors that might be amenable to modification from others that may not. The main contributors to AR at death for dementia in MRC CFAS were age (18%), small brain (12%), neocortical neuritic plaques (8%) and neurofibrillary tangles (11%), small vessel disease (12%), multiple vascular pathologies (9%), and hippocampal atrophy (10%). Other significant factors include cerebral amyloid angiopathy (7%) and Lewy bodies (3%).

Earlier CFAS analysis showed that Alzheimer pathology and vascular disease are frequently found in both demented and nondemented people [@pmed.1000180-NeuropathologyGroupofMRC1]. In the present more detailed analysis, with larger numbers, a moderate or severe neocortical NFT score emerged as the best pathological discriminator between the demented and nondemented groups. SVD emerged as an independent contributor to dementia risk in keeping with the evidence that SVD is the substrate for "subcortical vascular dementia" and contributes a major part of the burden of vascular cognitive impairment in the population [@pmed.1000180-Romn1]. We included deep subcortical WMLs within the vascular disease variable on the basis of evidence that they arise through vascular mechanisms [@pmed.1000180-Fernando2]. The estimates of AR at death reveal the relative importance of conventional pathological measures at the population level and show a range of pathological features contributing independently to dementia.

The major independent effects of age and relative low brain weight are interesting. The findings imply that other factors, not captured in this standardised approach to pathological analysis, are determinants of cognitive trajectory in older people. These may include synaptic integrity and the concentrations of peptide oligomers [@pmed.1000180-Kayed1],[@pmed.1000180-Terry1] but also interindividual variation in diverse factors that determine the neurobiological basis of "brain reserve," both innate (synaptic and neuronal density achieved into adult life, potential for neurogenesis, synaptic plasticity) and acquired (educational attainment, sustained intellectual, social, or physical activity in mid-life and old age) [@pmed.1000180-Valenzuela1].

Limitations of the Study {#s4a}
------------------------

In these six population samples from England and Wales the baseline response rate was good and unlikely to have been severely biased. Considerable attrition over time determines that those who remain in the study tend to have been younger and fitter at enrolment [@pmed.1000180-Matthews1]. The cohort reported here is based on individuals who were selected for more detailed assessment at the baseline and year 2 waves. Selection to this group is weighted towards the cognitively impaired, but with random selection from the full population, and created an older sample than the remainder of the baseline sample who died within the study period. Causes of death were similar in the two groups. Because the characteristics of both samples are known, a sensitivity analysis backweighting for this process (and for biases arising from selection into the neuropathology cohort) adequately adjust for these sampling effects, though not for unknown biases.

The number of interviews achieved for each individual during the study varied (96% had at least two and 30% had five or more). The AGECAT algorithm, applied to the data at last interview, has been validated against clinical diagnoses and shown to be comparable to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-IIIR) [@pmed.1000180-Kay1]. Fieldwork interviews were rarely started in acutely ill individuals so that diagnoses are unlikely to be influenced by confusional states. Although dementia on death certificates, insensitive but highly specific, was used to find incident dementia between last interview and death it was not used to indicate that an individual was not demented [@pmed.1000180-Bjertness1],[@pmed.1000180-Macera1]. Clinical judgements from informant reports were based on DSM-III-R, consistent with the previous validation studies using the GMS instrument. The extent of misclassification that would be necessary to create the findings observed here would need to be extreme and, when including only those with most recent interview data, the results are not affected.

Our previous report, clinically allocating differential diagnoses with a predominance of mixed pathology, remains robust [@pmed.1000180-NeuropathologyGroupofMRC1]. The factors identified in this analysis coexist and may interact mechanistically. Our analysis does not allow us to elucidate causal directions, which are better investigated using longitudinal analysis and in experimental work. A formal analysis of interactions between vascular and degenerative pathologies will be reported separately but the models here did not reveal interactions. The low prevalence of Lewy bodies in this sample (∼10%), reflects methods that were not optimised for the detection and screening of α-synucleinopathy because the neuropathology protocol predates the recognition of dementia with Lewy bodies, and the discovery of α-synuclein in Lewy bodies. Recent data on a subset of this cohort show synucleinopathy in 37% but no strong association with dementia [@pmed.1000180-Zaccai2]. Our data on brain weight are based on comparisons within sex but this measure does not distinguish atrophy from innate smallness, an issue that can only be addressed by systematic measurement of total cranial volume. Nor does it distinguish the contribution of vascular and neurodegenerative processes, or other correlates such as synaptic and dendritic loss that were not routinely measured in the pathology protocol. Standardised and validated assessment of vascular pathology is also needed in studies of the pathological correlates of dementia [@pmed.1000180-Jellinger1]. Perhaps the greatest difficulty in interpreting these data is that they derive from individuals who have died. People with dementia live for a variable length of time during which burdens of neuropathology are assumed to change. To extrapolate from this sample to an equivalent cross section of the living older population is problematic but, in the absence of methods to achieve in vivo measurement of all pathologies, this is the closest estimate it is currently possible to produce. In due course these data can be combined with modelling of in vivo population pathology derived from techniques to assess vascular and neuropathological changes (e.g., amyloid positron emission tomography \[PET\] scans).

The pathological features that are associated with dementia in this analysis are well supported by data from other large community-based and population-based studies. There is general agreement from studies of older people in the UK and the US that dementia is predominantly associated with mixed vascular and Alzheimer lesions together with other contributions of lesser degree (e.g., synucleinopathy) [@pmed.1000180-Sonnen1]--[@pmed.1000180-White1]. Those studies also contribute important insights into the potential interactions of vascular and degenerative pathologies that are not dealt with in the present analysis [@pmed.1000180-Sonnen1]--[@pmed.1000180-Chui1]. Some studies have emphasised the significance of microscopic infarcts compared to macroscopic infarcts in explaining the relationship between pathology and dementia [@pmed.1000180-Sonnen1],[@pmed.1000180-White1],[@pmed.1000180-Troncoso1], whereas others have not demonstrated an independent association of dementia risk with microscopic infarction [@pmed.1000180-Schneider1],[@pmed.1000180-Chui1]. In the present analysis we did not treat microinfarcts as a single pathological variable. Rather we chose to incorporate them into a global assessment of significant intrinsic SVD that also included microscopic evidence of severe arteriolar sclerosis and the presence of severe white matter attenuation. The Adult Changes in Thought study (ACT) has estimated the OR for dementia associated with Lewy bodies to be 5.1 (95% CI 1.37--18.96) on the basis of α-synuclein immunocytochemistry compared to 3.5 (95% CI 1.3--9.3) in this study using a less reliable method of detection. The estimates of AR at death for Lewy body pathology are 10% in ACT and 3% in MRC CFAS as reported here. In a subgroup of this CFAS cohort we demonstrated synucleinopathy in 37% of donated brains [@pmed.1000180-Zaccai2]. Other large cohorts have reported no clear predictive relationship between Lewy body pathology and dementia [@pmed.1000180-Parkkinen1]. Interpretation of data on Lewy body pathology in published multivariable analyses is further complicated by the recent recognition of "amygdala predominant disease" that may not be reliably detected using some screening protocols. Another pathology recently emphasised in older people is hippocampal sclerosis (HS), which has been shown to contribute a relative risk for dementia of 2.43 (95% CI 1.01--5.85). This is a microscopic diagnosis that was not included as a separate variable in our data. While we did include macroscopic hippocampal atrophy, and found that it contributes 10% of the AR at death for dementia, it is important for future studies to determine the correlation between macroscopic changes and the microscopic features of HS, which are also not yet the subject of diagnostic consensus or interlaboratory validation.

The present study supports the view that interventions that modify neuropathology related to dysmetabolism of specific proteins (βA4, tau) have the potential to impact on the population burden of dementia. In the context of presymptomatic treatment many individuals without risk of developing dementia would also be treated unless the predictive ability of clinical tests improves dramatically. However the estimates in this analysis indicate that individual pathologies contribute only modestly to the overall risk of dementia and emphasise the need to develop a range of protective strategies. Other factors, potentially less amenable to intervention play a role including age, and underlying innate or acquired factors relating to brain reserve, which, along with the effects of multiple pathological comorbidities, all play a part in the manifestation of dementia at the level of the population as a whole.
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